tofacitinib group:None

2 trials

Sponsors

Jining First People's Hospital, The First Affiliated Hospital of Chongqing Medical University

Conditions

Atopic Dermatitisrosacea

Phase 4

Clinical Efficacy and Safety Analysis of Janus Kinase Inhibitor in the Treatment of Moderate to Severe Atopic Dermatitis

ChiCTR2300071142

Jining First People's HospitalAtopic Dermatitis

Start: 2023-05-01Updated: 2023-11-27

Exploring the Efficacy and Safety of Tofacitinib in the Treatment of Rosacea

Active, not recruitingChiCTR2500096227

The First Affiliated Hospital of Chongqing Medical Universityrosacea

Start: 2025-01-20Updated: 2025-01-27